Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients.

by Nara, N., Murohashi, I., Suzuki, T., Yamashita, Y., Maruyama, Y., Aoki, N., Tanikawa, S., Onozawa, Y.
Published 1987

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

by Doi, T, Ohtsu, A, Yoshino, T, Boku, N, Onozawa, Y, Fukutomi, A, Hironaka, S, Koizumi, W, Sasaki, T
Published 2012

An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks i...

by Murakami, H., Kurata, T., Onozawa, Y., Watanabe, J., Ono, A., Takahashi, T., Yamamoto, N., Fujisaka, Y., Kiyota, H., Hayashi, H., Tanaka, K., Nakagawa, K., Kuroda, S.
Published 2014